Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography

Endoscopic retrograde cholangiopancreatography (ERCP) is a therapeutic procedure with the potential for a variety of adverse events, including acute pancreatitis, perforation, bleeding, and cardiopulmonary complications, which are well-established risk factors. It has become standard that patients u...

Full description

Saved in:
Bibliographic Details
Published inGastrointestinal endoscopy clinics of North America Vol. 23; no. 2; p. 385
Main Authors Balmadrid, Bryan, Kozarek, Richard
Format Journal Article
LanguageEnglish
Published United States 01.04.2013
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Endoscopic retrograde cholangiopancreatography (ERCP) is a therapeutic procedure with the potential for a variety of adverse events, including acute pancreatitis, perforation, bleeding, and cardiopulmonary complications, which are well-established risk factors. It has become standard that patients undergoing ERCP are carefully selected based on appropriate indications. Once an ERCP is undertaken, preprocedure and intraprocedure risks should be assessed and appropriate risk-reducing modalities, such as prophylactic pancreatic stent placement and rectal indomethacin, should be used if patient or procedural factors suggest an increased risk of post-ERCP pancreatitis.
ISSN:1558-1950
DOI:10.1016/j.giec.2012.12.007